Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com Prev Post Silver Crown Royalties Announces Closing of Final Tranche of its Non-Brokered Private Placement April 28, 2025 Next Post IBM pledges $150 billion to boost U.S. tech growth, computer manufacturing April 29, 2025 Related Posts CEO Appointment May 19, 2025 Exceptional Lithium Intercept Extends Red Mountain Discovery Further to the North May 19, 2025 WCN Raises A$14.4M at an Average 29% Premium to Market Close May 19, 2025